Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
Go back to Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.| (NASDAQ: SOPH) | Delayed: 5.34 -0.12 (2.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.46 | 52 Week High | $ | |||
| Open | $5.30 | 52 Week Low | $ | |||
| Day High | $5.59 | P/E | N/A | |||
| Day Low | $5.24 | EPS | $ | |||
| Volume | 354,583 | |||||
